Clement Loh
Keine laufenden Positionen mehr
Profil
Mr. Clement Loh is Investment Analyst at Anson Advisors, Inc.
Prior to joining Anson Group in 2010, Mr. Loh was employed as a Drug Safety Associate by Janssen-Ortho, Inc.
Mr. Loh earned his BS in Pharmacy and MBA in Finance from The University of Toronto.
Ehemalige bekannte Positionen von Clement Loh
| Unternehmen | Position | Ende |
|---|---|---|
Janssen, Inc.
 Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Corporate Officer/Principal | 01.01.2008 |
Anson Advisors, Inc.
 Anson Advisors, Inc. Investment ManagersFinance Anson Advisors, Inc. is a privately-held alternative asset management firm headquartered in Toronto, Canada. The firm was founded in 2003 as M5V Advisors, Inc. Anson Advisors serves as the investment manager to privately-held onshore investment partnerships and offshore investment companies. Anson Investments Master Fund (AIMF) is their flagship fund. | Analyst-Equity | - |
Ausbildung von Clement Loh
| University of Toronto | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Anson Advisors, Inc.
Anson Advisors, Inc. Investment ManagersFinance Anson Advisors, Inc. is a privately-held alternative asset management firm headquartered in Toronto, Canada. The firm was founded in 2003 as M5V Advisors, Inc. Anson Advisors serves as the investment manager to privately-held onshore investment partnerships and offshore investment companies. Anson Investments Master Fund (AIMF) is their flagship fund. | Finance |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
